help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenbaum, M.
Right arrow Articles by Leibel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenbaum, M.
Right arrow Articles by Leibel, R. L.

Journal of Clinical Endocrinology & Metabolism, Vol 75, 151-156, Copyright © 1992 by Endocrine Society


ARTICLES

Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature

M Rosenbaum, JM Gertner, N Gidfar, J Hirsch and RL Leibel
Division of Pediatric Endocrinology, New York Hospital-Cornell University Medical Center, New York.

Chronic administration of exogenous GH to GH-deficient children is associated with a selective depletion of the abdominal sc fat depot and a resultant relative increase in gluteal, relative to abdominal, adipocyte lipid content. In GH-deficient children, the degree of this change in relative lipid content per adipocyte appears to be correlated with decreases in sensitivity of abdominal subcutaneous fat to the antilipolytic action of insulin. We studied abdominal and gluteal sc adipose tissue from 10 children with short stature (height less than 5% ile, growth velocity less than 5 cm/yr, bone age delayed at least 2 yr), who were not GH deficient based upon provocative testing (non-GH- deficient short stature) 1) before beginning and 2) after 3 months of therapy with exogenous GH (Humatrope, 0.1 mg/kg sc 3 times/week). In abdominal and gluteal adipocytes, we measured lipid content, rates of reesterification of fatty acids released by ongoing lipolysis and rates of in vitro lipolysis and lipogenesis in response to insulin, adenosine, and various adrenoreceptor agonists. These biochemical measures were correlated with measures of statural growth and adipose tissue distribution in each subject. We found that GH therapy was associated with a significant reduction in abdominal adipocyte size (0.48 microgram +/- 0.08 lipid per cell prior to therapy vs. 0.43 microgram +/- 0.08 lipid per cell after therapy, P less than 0.05) and a significant increase in responsiveness of gluteal sc adipose tissue to the lipogenic actions of insulin. The significant correlations of changes in abdominal adipocyte volume with changes in regional adipose tissue insulin sensitivity that were noted in GH-deficient children were not noted in this subject population, perhaps due to effects of endogenous GH on pretreatment insulin responsiveness of adipose tissue. These data reaffirm that GH has site-specific effects on regional adipose tissue depots.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. S. Hannon, K. Danadian, C. Suprasongsin, and S. A. Arslanian
Growth Hormone Treatment in Adolescent Males with Idiopathic Short Stature: Changes in Body Composition, Protein, Fat, and Glucose Metabolism
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3033 - 3039.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. W. Speiser, M. C. J. Rudolf, H. Anhalt, C. Camacho-Hubner, F. Chiarelli, A. Eliakim, M. Freemark, A. Gruters, E. Hershkovitz, L. Iughetti, et al.
Childhood Obesity
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1871 - 1887.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick
Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span
Endocrinology, September 1, 2003; 144(9): 3799 - 3810.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. KAMEL, S. NORGREN, A. ELIMAM, P. DANIELSSON, and C. MARCUS
Effects of Growth Hormone Treatment in Obese Prepubertal Boys
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1412 - 1419.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Gravholt, O. Schmitz, L. Simonsen, J. Bulow, J. S. Christiansen, and N. Moller
Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E848 - E854.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. H. A. Ruvalcaba and G. B. Kletter
Abdominal Lipohypertrophy Caused by Injections of Growth Hormone: A Case Report
Pediatrics, August 1, 1998; 102(2): 408 - 410.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society